{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:45:07Z","timestamp":1762249507843,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejphar.2014.10.005","type":"journal-article","created":{"date-parts":[[2014,10,18]],"date-time":"2014-10-18T06:42:59Z","timestamp":1413614579000},"page":"36-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Reversal of novelty-induced hippocampal c-Fos expression in GluA1 subunit-deficient mice by chronic treatment targeting glutamatergic transmission"],"prefix":"10.1016","volume":"745","author":[{"given":"Milica","family":"Maksimovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu","family":"Aitta-aho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esa R.","family":"Korpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.10.005_bib1","doi-asserted-by":"crossref","first-page":"e38325","DOI":"10.1371\/journal.pone.0038325","article-title":"Importance of GluA1 subunit-containing AMPA glutamate receptors for morphine state-dependency","volume":"7","author":"Aitta-aho","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2014.10.005_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0014-5793(99)00685-7","article-title":"Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration","volume":"453","author":"Alvarez","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2014.10.005_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archpsyc.57.3.270","article-title":"Attenuation of the neuropsychiatric effects of ketamine with lamotrigine\u2014support for hyperglutamatergic effects of N-methyl-d-aspartate receptor antagonists","volume":"57","author":"Anand","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.10.005_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1022393604014","article-title":"Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate","volume":"28","author":"Angehagen","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2014.10.005_bib5","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.neuropharm.2011.06.005","article-title":"Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder?","volume":"62","author":"Barkus","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2014.10.005_bib6","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/00004647-200012000-00006","article-title":"NMDA and AMPA\/kainate glutamate receptors modulate dentate neurogenesis and CA3 synapsin-I in normal and ischemic hippocampus","volume":"20","author":"Bernabeu","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2014.10.005_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder","volume":"65","author":"Chiu","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2014.10.005_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/mp.2008.26","article-title":"Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol","volume":"14","author":"Colla","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.10.005_bib9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0028-3908(03)00270-3","article-title":"Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro","volume":"45","author":"Cunningham","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2014.10.005_bib10","doi-asserted-by":"crossref","first-page":"14282","DOI":"10.1073\/pnas.0401553101","article-title":"Cocaine-induced potentiation of synaptic strength in dopamine neurons: behavioral correlates in GluRA(\u2212\/\u2212) mice","volume":"101","author":"Dong","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.10.005_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0169-328X(94)00247-C","article-title":"Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia","volume":"29","author":"Eastwood","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ejphar.2014.10.005_bib12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0006-3223(96)00220-X","article-title":"Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-d-aspartate glutamate receptors within the medial temporal lobe in schizophrenia","volume":"41","author":"Eastwood","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.10.005_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","article-title":"Are the dorsal and ventral hippocampus functionally distinct structures?","volume":"65","author":"Fanselow","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2014.10.005_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.nbd.2010.08.005","article-title":"Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder?","volume":"40","author":"Fitzgerald","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2014.10.005_bib15","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1523\/JNEUROSCI.23-27-09116.2003","article-title":"Impaired long-term memory and NR2A-type NMDA receptor-dependent synaptic plasticity in mice lacking c-Fos in the CNS","volume":"23","author":"Fleischmann","year":"2003","journal-title":"J. Neurosci."},{"year":"2007","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","key":"10.1016\/j.ejphar.2014.10.005_bib16"},{"key":"10.1016\/j.ejphar.2014.10.005_bib17","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1157.2000.tb02164.x","article-title":"Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons","volume":"41","author":"Gibbs","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2014.10.005_bib18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1399-5618.2012.01033.x","article-title":"Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis","volume":"14","author":"Gigante","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ejphar.2014.10.005_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.neubiorev.2007.05.007","article-title":"Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement","volume":"31","author":"Gould","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2014.10.005_bib20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","article-title":"Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy","volume":"52","author":"Hanada","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2014.10.005_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0140-6736(91)93392-M","article-title":"Decreased hippocampal expression of a glutamate receptor gene in schizophrenia","volume":"337","author":"Harrison","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.10.005_bib22","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.10.005_bib23","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2001.00349.x","article-title":"Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate","volume":"77","author":"Hassel","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2014.10.005_bib24","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1073\/pnas.092157999","article-title":"Molecular dissection of hippocampal theta-burst pairing potentiation","volume":"99","author":"Hoffman","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.10.005_bib25","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1176\/appi.ajp.157.11.1811","article-title":"Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia","volume":"157","author":"Ibrahim","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.10.005_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neubiorev.2009.07.010","article-title":"Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review","volume":"34","author":"Inta","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2014.10.005_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1113\/jphysiol.2003.053637","article-title":"A juvenile form of postsynaptic hippocampal long-term potentiation in mice deficient for the AMPA receptor subunit GluR-A","volume":"553","author":"Jensen","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2014.10.005_bib28","doi-asserted-by":"crossref","first-page":"17846","DOI":"10.1073\/pnas.0508910102","article-title":"A mechanism underlying AMPA receptor trafficking during cerebellar long-term potentiation","volume":"102","author":"Kakegawa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.10.005_bib29","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.neuropharm.2005.08.007","article-title":"Valproic acid reduces enhanced vesicular glutamate transporter immunoreactivities in the dentate gyrus of the seizure prone gerbil","volume":"49","author":"Kang","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2014.10.005_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/REVNEURO.2004.15.5.333","article-title":"A behavioral assessment of hippocampal function based on a subregional analysis","volume":"15","author":"Kesner","year":"2004","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2014.10.005_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0197-0186(98)00023-0","article-title":"c-Fos as a transcription factor: a stressful (re)view from a functional map","volume":"33","author":"Kovacs","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2014.10.005_bib32","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1111\/j.1528-1157.1991.tb05882.x","article-title":"Neurochemical and behavioral-aspects of lamotrigine","volume":"32","author":"Leach","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2014.10.005_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1017\/S1461145712000429","article-title":"Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction","volume":"16","author":"Leng","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2014.10.005_bib34","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1995.tb05996.x","article-title":"Antiepileptic drug mechanisms of action","volume":"36","author":"Macdonald","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2014.10.005_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1073858409336093","article-title":"The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders","volume":"15","author":"Machado-Vieira","year":"2009","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ejphar.2014.10.005_bib36","doi-asserted-by":"crossref","first-page":"e100188","DOI":"10.1371\/journal.pone.0100188","article-title":"Chronic treatment with mood-stabilizers attenuates abnormal hyperlocomotion of GluA1-subunit deficient mice","volume":"9","author":"Maksimovic","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2014.10.005_bib37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0006-3223(00)00979-3","article-title":"Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness","volume":"48","author":"Manji","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.10.005_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0361-9230(01)00523-8","article-title":"Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder","volume":"55","author":"Meador-Woodruff","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2014.10.005_bib39","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1523\/JNEUROSCI.23-03-01041.2003","article-title":"Selective disruption of stimulus-reward learning in glutamate receptor gria1 knock-out mice","volume":"23","author":"Mead","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.10.005_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00213-003-1440-z","article-title":"Acute mania is accompanied by elevated glutamate\/glutamine levels within the left dorsolateral prefrontal cortex","volume":"168","author":"Michael","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.10.005_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1097-4695(19990205)38:2<234::AID-NEU6>3.0.CO;2-G","article-title":"Novelty-induced increased expression of immediate-early genes c-fos and arg 3.1 in the mouse brain","volume":"38","author":"Montag-Sallaz","year":"1999","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.ejphar.2014.10.005_bib42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tvjl.2005.11.007","article-title":"The role of glutamate in central nervous system health and disease\u2014a review","volume":"173","author":"Platt","year":"2007","journal-title":"Vet. J."},{"key":"10.1016\/j.ejphar.2014.10.005_bib43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1460-9568.2010.07485.x","article-title":"Excessive novelty-induced c-Fos expression and altered neurogenesis in the hippocampus of GluA1 knockout mice","volume":"33","author":"Procaccini","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.10.005_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuroscience.2013.07.010","article-title":"Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2\/3 agonist LY354740","volume":"250","author":"Procaccini","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2014.10.005_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ane.12100","article-title":"Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist","volume":"127","author":"Rogawski","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ejphar.2014.10.005_bib46","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1460-9568.2009.06677.x","article-title":"Induction and expression of GluA1 (GluR-A)-independent LTP in the hippocampus","volume":"29","author":"Romberg","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.10.005_bib47","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2014.10.005_bib48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1101\/lm.1339109","article-title":"Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model","volume":"16","author":"Sanderson","year":"2009","journal-title":"Learn. Mem."},{"key":"10.1016\/j.ejphar.2014.10.005_bib49","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.neuropsychologia.2010.03.018","article-title":"Spatial working memory deficits in GluA1 AMPA receptor subunit knockout mice reflect impaired short-term habituation: evidence for Wagner\u05f3s dual-process memory model","volume":"48","author":"Sanderson","year":"2010","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.ejphar.2014.10.005_bib50","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2014.10.005_bib51","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1046\/j.1471-4159.1998.71062454.x","article-title":"Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of \u201cneuroleptic-free\u201d schizophrenics: evidence on reversible up-regulation by typical neuroleptics","volume":"71","author":"Sokolov","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2014.10.005_bib52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1601-1848.2004.00075.x","article-title":"Reduced aggression in AMPA-type glutamate receptor GluR-A subunit-deficient mice","volume":"3","author":"Vekovischeva","year":"2004","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.ejphar.2014.10.005_bib53","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1523\/JNEUROSCI.21-12-04451.2001","article-title":"Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits","volume":"21","author":"Vekovischeva","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.10.005_bib54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.mp.4002056","article-title":"Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and \u2018schizophrenia-related\u2019 behaviors","volume":"13","author":"Wiedholz","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.10.005_bib55","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.bjp.0702096","article-title":"Frequency-dependent inhibition of neuronal activity by topiramate in rat hippocampal slices","volume":"125","author":"Wu","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.005_bib56","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1476-5381.2011.01318.x","article-title":"Predictive animal models of mania: hits, misses and future directions","volume":"164","author":"Young","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.005_bib57","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1126\/science.284.5421.1805","article-title":"Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning","volume":"284","author":"Zamanillo","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2014.10.005_bib58","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1528-1157.1997.tb01135.x","article-title":"Lamotrigine reduces voltage-gated sodium currents in rat central neurons in culture","volume":"38","author":"Zona","year":"1997","journal-title":"Epilepsia"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914007110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914007110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:03:36Z","timestamp":1762142616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914007110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":58,"alternative-id":["S0014299914007110"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.10.005","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of novelty-induced hippocampal c-Fos expression in GluA1 subunit-deficient mice by chronic treatment targeting glutamatergic transmission","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}